Immediate Impact
56 standout
Citing Papers
Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
2025 Standout
Traditional Chinese medicine in lung cancer treatment
2025 Standout
Works of Xue Wang being referenced
Combined analysis of receptor expression reflects inter-and intra-tumor heterogeneity in HR+/HER2+ breast cancer
2022
ALDH3A1 acts as a prognostic biomarker and inhibits the epithelial mesenchymal transition of oral squamous cell carcinoma through IL-6/STAT3 signaling pathway
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Xue Wang | 153 | 261 | 93 | 117 | 84 | 622 | |
| Li Li | 117 | 383 | 81 | 225 | 59 | 726 | |
| Yutaka Hoshino | 97 | 273 | 63 | 108 | 57 | 639 | |
| Shujuan Huang | 111 | 306 | 58 | 94 | 34 | 659 | |
| Shan Cheng | 109 | 363 | 91 | 104 | 63 | 702 | |
| Antônio Ricardo de Toledo Gagliardi | 87 | 296 | 57 | 86 | 41 | 738 | |
| Naomi Watanabe | 111 | 313 | 95 | 50 | 62 | 716 | |
| Magdalena Izdebska | 117 | 400 | 56 | 97 | 57 | 717 | |
| Xiaoyong Dai | 102 | 327 | 61 | 64 | 54 | 569 | |
| Qiong Du | 114 | 275 | 75 | 216 | 46 | 604 | |
| Yu Zhang | 106 | 271 | 71 | 103 | 43 | 631 |
All Works
Login with ORCID to disown or claim papers
Loading papers...